Depression News

DENVER –Adults who used a digital mental health aid app within a hybrid treatment setting experienced a decrease in depression and anxiety, an expert reported at the Anxiety and Depression Association of America annual conference.

DENVER – Mental health of young adults showed little change at the outset of COVID-19, but appeared to worsen as the pandemic continued, according to a presentation at the Anxiety and Depression Association of America annual conference.

DENVER – Understanding biomechanisms and other factors related to trauma that lead to suicidality are crucial for better therapeutic outcomes, an expert said at the Anxiety and Depression Association of America annual conference.

Women who took antidepressant medication had persistent depressive and anxiety symptoms during pregnancy and postpartum, with some women experiencing increased anxiety symptoms, data showed.

People who committed suicide by firearm were less likely to seek treatment and have previous suicide attempts, yet more likely to reveal their thoughts and plans, compared with others who took their own life.

Independent of treatment, socioeconomic factors such as employment are closely associated with prognosis for adults with depression, according to a systematic review and meta-analysis published in JAMA Psychiatry.

Social determinants of health, including food insecurity, are prevalent among adults with self-reported rheumatoid arthritis, according to a study published in BMC Rheumatology.

Novamind Inc., a company specializing in psychedelic medicine, announced it will conduct a phase 2 clinical trial examining psilocybin for major depressive disorder.

The COVID-19 pandemic disrupted progress toward gender equity in medicine that may resonate for years to come, according to experts.

Utilizing decision aids before discussing treatment options gives patients with chronic kidney disease hope and improves patients’ motivation to treat the disease, according to a speaker at the virtual Annual Dialysis Conference.